A Phase 1 Study of OSI-906 in Combination with AZD6244 Hydrogen Sulfate in Patients with Ras/Raf/GNAQ Mutated Advanced Cancer Refractory to Standard Therapy
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Linsitinib (Primary) ; Selumetinib (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 08 Oct 2013 New trial record